Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
563,000
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
243,200
-
Shares change
-
+155,742
-
Total reported value, excl. options
-
$258,000
-
Value change
-
+$161,017
-
Number of buys
-
9
-
Number of sells
-
-5
-
Price
-
$1.06
Significant Holders of Bluejay Diagnostics, Inc. - Common Stock (BJDX) as of Q2 2022
15 filings reported holding BJDX - Bluejay Diagnostics, Inc. - Common Stock as of Q2 2022.
Bluejay Diagnostics, Inc. - Common Stock (BJDX) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 243,200 shares
of 563,000 outstanding shares and own 43.2% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (50,501 shares), Virtu Financial LLC (42,912 shares), SABBY MANAGEMENT, LLC (32,895 shares), CITADEL ADVISORS LLC (30,440 shares), MILLENNIUM MANAGEMENT LLC (25,575 shares), TWO SIGMA SECURITIES, LLC (21,242 shares), Verition Fund Management LLC (15,016 shares), GEODE CAPITAL MANAGEMENT, LLC (12,420 shares), NORTHERN TRUST CORP (11,699 shares), and ADVISOR GROUP HOLDINGS, INC. (500 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.